










































The regulation of interleukin-8 by hypoxia in human
macrophages--a potential role in the pathogenesis of the acute
respiratory distress syndrome (ARDS)
Citation for published version:
Hirani, N, Antonicelli, F, Strieter, RM, Wiesener, MS, Ratcliffe, PJ, Haslett, C & Donnelly, SC 2001, 'The
regulation of interleukin-8 by hypoxia in human macrophages--a potential role in the pathogenesis of the
acute respiratory distress syndrome (ARDS)' Molecular Medicine, vol 7, no. 10, pp. 685-97.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Available under Open Access
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
Molecular Medicine 7(10): 685–697, 2001
© 2001 The Picower Institute Press
The Regulation of Interleukin-8 by Hypoxia in Human Macrophages—
A Potential Role in the Pathogenesis of the Acute Respiratory Distress
Syndrome (ARDS) 
Nikhil Hirani, Frank Antonicelli, Robert M Strieter,1 Michael S. Wiesener,2 Chris Haslett, 
and Seamas C. Donnelly
The Respiratory Medicine Unit, Centre for Inﬂammation Research, University of Edinburgh, Edinburgh, UK
1Division of Pulmonary and Critical Care Medicine, University of California at Los Angeles, School of
Medicine, Los Angeles, CA, USA
2Wellcome Trust Centre for Human Genetics, Oxford, UK
Communicated by R. Bucala. Accepted August 30, 2001
Abstract
Background: The acute respiratory distress syndrome
(ARDS) represents a form of severe acute inﬂammatory
lung disease. We have previously demonstrated signiﬁ-
cantly raised interleukin-8 (IL-8) levels in the lungs of at-
risk patients that progress to ARDS, and identiﬁed the
alveolar macrophage as an important source of this
chemokine. We wished to extend this study in a well-
deﬁned group of patients with major trauma, and to in-
vestigate potential mechanisms for rapid intrapulmonary
IL-8 generation.
Materials and Methods: Patients with major trauma un-
derwent brochoalveolar lavage (BAL) and IL-8 levels were
measured in BAL ﬂuid by ELISA. Human macrophages
were derived from peripheral blood monocytes from
healthy volunteers. Rabbit alveolar macrophages were
obtained from ex-vivo lavage of healthy rabbit lungs.
Macrophages were culture under normoxic or hypoxic
(PO2 26 mmHg) conditions. IL-8 and other proinﬂam-
matory mediator expression was measured by ELISA,
northern blotting or multi-probe RNase protection assay.
Results: In patients with major trauma, IL-8 levels were
signiﬁcantly higher in patients that progressed to ARDS
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compared to those that did not (n 56, P 0.0001). High
IL-8 levels negatively correlated with PaO2/FiO2 (r 
0.56, P 0.001). In human monocyte derived macro-
phages hypoxia rapidly upregulated IL-8 protein (within
2 hours) and mRNA expression (within 30 mins). Acute
hypoxia also increased rabbit alveolar macrophage IL-8
expression. Hypoxia increased DNA binding activity of
AP-1 and C/EBP but not NF-B. Hypoxia induced HIF-1
expression, but cobaltous ions and desferrioxamine did not
mimic hypoxic IL-8 induction. Hypoxia downregulated a
range of other proinﬂammatory mediators, including
MCP-1 and TNF-. Both the pattern of cytokine expres-
sion and transcription factor activation by hypoxia was
different to that seen with endotoxin.
Conclusions: Rapidly raised intrapulmonary IL-8 levels
are associated with ARDS progression in patients with ma-
jor trauma. Acute hypoxia, a clinically relevant stimulus,
rapidly and selectively upregulates IL-8 in macrophages
associated with a novel pattern of transcription factor acti-
vation. Acute hypoxia may represent one of potentially
several proinﬂammatory stimuli responsible for rapid in-
trapulmoanry IL-8 generation in patients at-risk of ARDS.
Introduction
The acute respiratory distress syndrome (ARDS) rep-
resents a severe form of acute inﬂammatory lung dis-
ease. The lung injury is characterised by an intense,
predominantly neutrophilic, inﬂammatory inﬁltrate
in the pulmonary vasculature and airspaces (1–3).
There is currently no speciﬁc therapy for this disor-
der and the associated mortality is 50% or higher (4).
A variety of clinical conditions or insults including
major trauma, sepsis syndrome, acid aspiration and
severe pneumonia, predispose to the development of
ARDS, typically several hours or days after the initial
insult. Hence, ARDS often occurs in the context of a
severe systemic inﬂammatory response. Only a sub-
group of between 2–35% of at-risk patients however
progress to full-blown ARDS (5).
We have previously observed that in bron-
choalveolar lavage (BAL) ﬂuid samples taken within
a few hours of the initiating insult, levels of inter-
leukin-8 (IL-8) were signiﬁcantly higher in those
that progressed to ARDS compared to those that did
not. Interleukin-8 is a potent neutrophil chemokine,
and immunohistochemical analysis has implicated
the alveolar macrophage as an important source of
this mediator (6). Other investigators have also iden-
tiﬁed this chemokine as an early marker of inﬂam-
mation, present in tissue before the onset of neu-
trophil inﬂux (7,8). Recently, raised intrapulmonary
IL-8 levels in donor lungs have been shown to be
associated with development of graft dysfunction in
the recipients (9). Investigating potential mecha-
nisms by which intrapulmonary IL-8 is rapidly gen-
erated therefore may be key to our understanding of
the pathogenesis of lung injury.
In this paper we report our extended studies of
multiple trauma patients, a well-deﬁned group ‘at-
risk’ of developing ARDS. We conﬁrm our earlier
ﬁnding that raised bronchoalveolar lavage (BAL) IL-8
levels in the very early risk period (median 95 mins
post-trauma) are closely associated with ARDS 
disease progression. The mechanisms by which
macrophages may rapidly upregulate IL-8 under such
circumstances are unknown. Bacterial endotoxin-
derived lipopolysaccaride (LPS) is a classical proin-
ﬂammatory stimulus that may play a role in the
development of the systemic inﬂammatory response
and acute lung injury following major trauma (10,11).
However, we found no association between circulat-
ing or intrapulmonary endotoxin and IL-8 levels or
progression to ARDS. We postulated that physiologi-
cal events occurring in the ﬁrst few hours following
admission to the Emergency Room may result in in-
creased IL-8 generation. A relationship between pa-
tient hypoxia at presentation, as manifest by a reduced
PaO2/FiO2 ratio, and raised alveolar IL-8 levels was
identiﬁed, invoking the hypothesis that hypoxia may
play an initial role in IL-8 generation.
In in vitro studies of human macrophages we have
demonstrated that acute hypoxia rapidly and selec-
tively upregulated IL-8 generation. The hypoxic stim-
ulus induced a pattern of chemokine and transcrip-
tion factor activation signiﬁcantly different from that
seen with LPS, However, IL-8 generation by hypoxia
in vitro was found to be less than could account for the
differences observed in patient studies. This suggests
that in addition to hypoxia, other proinﬂammatory
stimuli such as reoxygenation and pulmonary baro-
trauma during resuscitation may also play a role in
rapid intrapulmonary IL-8 production.
Materials and Methods
Patient Studies:
Patient enrolment and Bronchoalveolar Lavage—Consecu-
tive patients with severe multiple trauma and requir-
ing intubation in the Emergency Room (n 56) were
enrolled at the Royal Inﬁrmary Edinburgh, Scotland
over a period of 36 months. Consent was obtained
from relatives or guardians and the study approved by
the Lothian Health Board Ethics Committee. The ex-
tent of trauma was assessed by the injury severity
score (ISS); severe trauma was deﬁned as an ISS score
of15 (12). A chest radiograph was taken on all
patients as soon as clinically appropriate in the
emergency room. The initial ratio between arterial
oxygen tension (PaO2) and fractional concentration of
inspired oxygen (FiO2), a measure of patient oxygena-
tion and gas exchange, was recorded in the emergency
room. All patients intubated for clinical indications
underwent bronchoalveolar lavage (BAL) in the emer-
gency room. The technique for BAL and processing of
ﬂuid obtained has previously been described (6). A 10
ml venous blood sample, obtained immediately prior
to BAL, was centrifuged at 400 g for 10 minutes at 4C
and the plasma stored at 70C for later analysis.
Measurement of BAL ﬂuid IL-8, by standard ELISA as
previously described (6). BAL ﬂuid total protein was
measured using a commercially available kit (Pierce,
Rockford, IL). Serum and BAL endotoxin levels were
measured by the limulus amoebocyte lysate assay as
previously described (13). Subsequent development
of ARDS was deﬁned using the European/American
Consensus criteria (13) which requires the presence of
bilateral pulmonary inﬁltrates on the chest radiograph
and a PaO2/FiO2 ratio of200 mmHg.
In Vitro Studies: 
Cell Isolation and Culture
Human macrophages—Blood from normal, healthy
volunteers was collected in citrated tubes and pe-
ripheral blood mononuclear cells (PBMCs) obtained
by separation through Percoll (Pharmacia Biotech-
nologies, St. Albans, UK) density gradient centrifu-
gation as previously described (14,15). Autologous
serum was prepared by adding CaCl2 (10 mM ﬁnal
concentration) to plasma and incubating at 37C 
for 1 hour. PBMCs were resuspended in complete
medium (Iscove’s Modiﬁed Dulbecco’s Medium
suplemented with 1 mM glutamine, 100 U/ml peni-
cillin and 100 g/ml streptomycin, Life Technologies,
Paisley, UK) at a concentration of 4 106 cells/ml and
3 ml aliquots plated into 35 mm plastic culture wells
(CorningCostar, High Wycombe, UK). Monocytes
were allowed to selectively adhere for 1 hour in stan-
dard conditions (37C in humidiﬁed 95% air/5%
CO2). Non-adherent cells were washed away with
warm complete medium and adherent monocytes
overlaid with 3 ml of complete medium supple-
mented with 10% autologous serum. Monocytes
were allowed to mature to macrophages over 6 days
following which overlying medium was removed
and the cells gently rinsed with warm medium.
Rabbit alveolar macrophages—Adult female spe-
ciﬁc pathogen-free (SPF) New Zealand white rabbits
(Charles River Ltd. Margate, Kent) were sedated with
intramuscular fentanyl citrate and ﬂuanisone (Hyp-
norm® 0.3 ml/kg bolus followed by 0.3 ml/kg/h,
Janssen-Cilag Ltd., High Wycombe, UK) then anaes-
thetised with intravenous (i.v.) midazolam (Hyp-
novel® @ 2 mg/ml, 0.75 ml/kg, Roche Products Ltd.,
Welwyn Garden City, UK) via marginal ear vein. A
tracheotomy was performed and a purpose-made en-
dotracheal tube inserted and secured. Animals were
then euthanased with sodium pentabarbitone
(Sagatal, 200 mg/ml, Rhone Merieux Ltd., Harlow,
Essex) and the lungs immediately removed and
placed on ice. Both lungs were lavaged ex-vivo by se-
quential instilling and aspiration of 40 ml aliquots of
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After washing, 100 l per well of secondary biotiny-
lated antibody was added and the plates incubated
for 2 hours at RT. Plates were washed and 100 l
streptavidin-peroxidase conjugate (Dako, Denmark)
diluted 1 in 20,000 was incubated in the wells for 
20 minutes. Substrate solution consisting of TMB 
100 g/ml, 4.5 mM H2O2 in 0.1 M sodium acetate-
citrate pH 4.9 was added and the plates incubated in
darkness at RT to the desired extinction. The reaction
was stopped with 50 l of 0.5 M H2SO4. Plates were
read at 450 nm in an plate reader (Dynatech MR5000).
Sample results were extrapolated from a standard
curve derived with recombinant human (rh) IL-8
(WHO International Standard, NIBSC, Herts, UK),
rhTNF- or rhIL-1 (R&D Systems).
RNA Extraction and Northern Blotting
Total RNA from cells was extract using TRIzol reagent
(Life Technologies) as per the manufacturers protocol.
Equal quantities of RNA (15 g per lane) were sepa-
rated on a 1.2% formaldehyde–agarose gel (40 mM
3-morpholinopropanesulphonic acid, pH 7.0, 10 mM
sodium acetate, 1 mM EDTA, 2 M formaldehyde)
and then transferred to nylon membrane (Du Pont
NEN Genescreen Plus) by capillary action in 20
SSC. The RNA was wet cross-linked under UV-light
and pre-hybridised for 2 hr at 65C in buffer con-
taining 0.5 M NaHPO4, 7% SDS and 1 mM EDTA
(pH 7.2). Fresh buffer containing (-32P) dCTP-
labelled IL-8 cDNA probe was then added and
hybridisation continued for 18 hours at 65C. The
membranes were washed three times in 2 SSC,
0.1% SDS, once at 65C and twice at room tem-
perature. Membranes were exposed to Biomax MR
or X-Omat ﬁlms (Kodak) with intensifying screens
at 70C. Membranes were subsequently stripped
with boiling 0.1% SDS and re-probed with a house-
keeping 18s cDNA probe.
Probe Synthesis and Labelling
A 747 bp length human IL-8 cDNA probe was gener-
ated by RT-PCR from mRNA derived from human
monocytes stimulated with LPS. The primers used
were 5’-ATT-TCT-GCA-GCT-CTG-TGT-GA-3’ and 5’-
TGT-GGA-TCC-TGG-CTA-GCA-GA-3’. Fifty nano-
grams of IL-8 probe was labelled with 50 Ci of 
(-32P) dCTP (Amersham Life Science Ltd., Bucks,
UK) as per the manufacturers protocol (ReadyToGo™,
Pharmacia Biotechnologies, St. Albans, UK). Twenty
nanograms of the 18s housekeeping cDNA probe (a
generous gift from Dr Irfan Rahman, Edinburgh, UK)
was similarly labelled.
Rabbit Interleukin-8 Reverse Transcription PCR (RT-PCR)
IL-8 mRNA expression from rabbit alveolar macro-
phages was determined by semi-quantitative RT-PCR.
First strand cDNA was synthesised from 1 g total
RNA using AMV reverse transcriptase (Promega,
Southampton, UK). Rabbit IL-8 primers, designed
from the GenBank succession sequence number
cold (4C) PBS via a quill placed in the tracheostomy
tube. Lavaging was continued until there was an
appreciable loss of opalescence in the lavage ﬂuid.
Alveolar cells were washed in PBS (4C) twice and
resuspended in complete medium. This process
yielded alveolar macrophages of98% purity 95%
viability, as assessed by Wright-Giemsa staining of
cytospins and trypan blue exclusion (data not
shown). Alveolar macrophages were aliquoted in 
6-well plates at 4 106 cells/3 ml complete medium
with 10% heat-inactivated foetal calf serum (FCS)
per well. Cells were cultured overnight under stan-
dard conditions to allow adherance and then used in
hypoxia experiments.
Hypoxic incubation of macrophages—Cells to be
cultured under normoxic conditions were placed in a
standard incubator at 37C, 95% air/5% CO2. In pre-
liminary experiments, cells to be incubated under hy-
poxic conditions were placed in an anaerobic incuba-
tor at 37C (Napco, Precision Scientiﬁc Inc, Ill. USA)
with an infused gas mixture of 95% N2/5% CO2. We
established that our key ﬁnding with regard to IL-8
protein secretion and transcription were reproducible
in an alternative anaerobic chamber (MK3 Anaerobic
Workstation, Don Whitley Scientiﬁc Ltd. UK) which
maintained an environment at 37C/80% N2/10%
H2/10% CO2. This latter chamber was subsequently
used in hypoxia experiments. For both normoxia and
hypoxia experiments, cells were overlayed with 1 ml
of preincubated complete medium supplemented
with 2% autologous serum (or 10% FCS for rabbit
alveolar macrophages). The PO2 of the normoxic and
hypoxic medium at steady-state was 150 mmHg
and 26 mmHg respectively as measured by dis-
solved oxygen meter (ISO2 with OXEL-1 probe,
World Precision Instruments, Inc. Florida, USA).
Cells were cultured for up to 2 hours and viability
was not affected as measured by trypan blue exclu-
sion and LDH assay (data not shown).
Supernatants overlying adherent macrophages
were collected by gentle aspiration. Adherent macro-
phages were immediately placed on ice and lysed for
protein or RNA extraction. In the case of hypoxic
cells, these manipulations were performed inside the
anaerobic chamber to avoid reoxygenation.
Enzyme-linked Immunosorbent Assay
Monoclonal and biotinylated anti-human IL-8, tu-
mour necrosis factor- (TNF-) and interleukin-I
(IL-1) antibodies were obtained from R&D Systems
and used at concentrations recommended in the
manufacturers ELISA protocol. Brieﬂy, ﬂat-bottomed
96-well microtitre plates (E.I.A/R.I.A. plate, Costar,
Cambridge, MA) were coated with 100 l per well of
the monoclonal antibody in PBS overnight at room
temperature (RT), washed and non-speciﬁc binding
sites blocked with 1% BSA in PBS. 100 l aliquots
of macrophage-derived supernatants or cell lysates
(obtained by lysing cells in 0.1% Nonidet-P40 in
PBS) were added and incubated for 2 hours at RT.
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M57439 (16) were; 5’-ATG AAC TCC AAG CTG GCT-
3’ (sense) and 5’-TTA TGA CTC TTG CTG CTC AGC-
3’ (antisense). PCR conditions were: 94C for 1 min
(denaturation), 55C for 1 min (annealing) and 72C
for 1 min (extension) for 26 cycles followed by a ﬁnal
5 min extension at 72C. IL-8 product was expressed
relative to that obtained by RT-PCR for the house-
keeping gene human -actin, the primers for which
were: 5’-CCA CCA ACT GGG ACG ACA TG-3’ (sense)
and 5’-GTC TCA AAC ATG ATC TGG GTC ATC-3’ (an-
tisense). The PCR conditions for -actin were: 94C
for 1 min (denaturation), 60C for 1 min (annealing)
and 72C for 1 min (extension) for 26 cycles followed
by a ﬁnal 5 min extension at 72C. Preliminary exper-
iments had established that a limited cycle number of
26 yielded PCR product within the linear ampliﬁca-
tion range for both IL-8 (306 base pairs) and human
-actin (180 base pairs).
Electromobility Gel-Shift Assay
Total nuclear proteins were extracted from cells using
a method modiﬁed from that previously described
(16). Brieﬂy, macrophages were kept on ice and
scraped into cold buffer containing 10 mM HEPES—
KOH pH 7.8, 2 mM MgCl2, 1 mM dithiothreitol, 
0.1 mM EDTA protease inhibitor cocktail (Com-
plete™, Boehringer Mannheim). The cells were al-
lowed to swell on ice for 15 mins then lysed by adding
0.4% Nonidet P40 and centrifuged (12000 g for 1 min
at 4C). The supernatant was carefully removed and
the pellet resuspended in 50 l of cold buffer con-
taining 50 mM HEPES—KOH pH 7.8, 50 mM KCl,
300 mM NaCl, 1 mM dithiothreitol, 10% glycerol, 
0.1 mM EDTA and protease inhibitor cocktail. Fol-
lowing 20 mins incubation at 4C with gentle agita-
tion and centrifugation (12000 g for 1 min at 4C) the
supernatant was carefully removed and protein con-
tent assayed by BCA protein assay (Pierce, Rockford,
IL). The binding reaction was performed at RT as fol-
lows: 4 ug aliquots of protein were incubated for 
5 mins in binding buffer containing 5 mM Tris, 0.5 mM
EDTA, 8% glycerol, 1 mM MgCl2, 50 mM NaCl,
0.5 mM DTT and 1.2 ug of polydI-dC and then a fur-
ther 15 mins with an appropriate (-32P)-labelled
oligonucleotide. In the case of supershift assays nu-
clear extracts were ﬁrst co-incubated at 4C with rab-
bit anti-human polyclonal IgG antibodies to p50 and
p65 (Santa Cruz) for 4 hours or with antibodies to 
c-jun and c-fos (Santa Cruz) for 20 hours in binding
buffer minus DTT. These were subsequently incu-
bated at RT with appropriate (-32P)-labelled
oligonucleotide in the presence of 0.5 mM DTT. The
reaction mixtures were separated on a 6% polyacry-
lamide gel at 180 V at room temperature in 0.5% TBE
buffer. After drying, gels were exposed to X-ray ﬁlm
and densitometry performed. The double stranded
oligonucleotide probes used were as follows: AP-1
5’-AGT GTG ATG ACT CAG GTT TGC-3’, C/EBP 5’-
CAT CAG TTG CAA ATC GTT AAC-3’, NFkB 5’-TCG
TGG AAT TTC CTC TGA CAT-3’.
Immunoblotting for HIF-1 Protein in Macrophages
Total cellular protein was extracted by a Trizol base
method as per the manufacturers protocol. Immuno-
blotting for HIF-1 with MoAb 28B has been previ-
ously described (17). Brieﬂy, proteins were resolved
in SDS/10% polyacrylamide gel, transferred over-
night to Immobolin P (Millipore, Bedford, MA) and
exposed to HIF-1 antibody. Detection was with
HRP-conjugated goat anti-mouse Igs (DAKO, Ely,
UK) and enhanced chemiluminescence. After analy-
sis, membranes were stained with Ponceau S to ver-
ify equal protein loading and transfer.
RNAse Protection Assay for Multiple Chemokines
RNAse protection assays were performed using the Ri-
boQuant® multi-probe RNase protection assay system
(Pharmingen, San Diego, CA) as per the manufacturers
protocol. Brieﬂy, total RNA from human macrophages
was obtained as described. (-32P)-labelled anti-sense
RNA probes were generated from multi-probes using
T7 polymerase. Multi-probe hCK-5 contains multiple
chemokine templates. Multi-probe hCK-3 includes a
TNF- template. Both probe sets include templates for
the house-keeping genes L-32 and GAPDH. Five
micrograms of total RNA was hybridised with 3 
105cpm of labelled hCK-5 or hCK-3 probe at 56
overnight. Free-probe and other single stranded RNA
was digested with RNase A and protected hybridised
RNA species were resolved on a 6% denaturing poly-
acrylamide sequencing gel and exposed to X-ray ﬁlm
at 70C.
Statistical Analysis
Patient data is presented as mean	SD and analysed
by the non-parametric Mann-Whitney U test. Corre-
lation was analysed by Pearson r. In vitro data is pre-
sented as mean	S.E.M unless otherwise stated and
analysed by Mann-Whitney U or t-test for normally
distributed data. Signiﬁcance testing was two-tailed
and a value of P 0.05 was considered signiﬁcant.
Results
Patient Studies
Fifty-six trauma patients, median age 48 years (range
18–89) were enrolled in the study. The median ISS
was 25 (range 16–66). A chest radiograph was taken
and reviewed within 4 hours of admission for all pa-
tients. No patients had radiographic evidence of
ARDS at this time. BAL sampling as performed at a
median time of 95 mins (range 30–240) after the
trauma event. Seventeen patients subsequently pro-
gressed to ARDS and mean BAL IL-8 (pg/ml) levels
were signiﬁcantly higher in these patients compared
to those who did not (1425	 1841 v 206	 288
pg/ml, P 0.0001) (Fig. 1). Bronchoalveolar lavage
total protein levels (as a measure of lung leak), en-
dotoxin levels, and neutrophil counts were not sig-
niﬁcantly different between patients who did and
did not progress to ARDS (Table 1.) and in 7 of the
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Fig. 2. Correlation between PaO2/FiO2 ratio and raised IL-8
at admission. Initial PaO2/FiO2 ratio plotted against BAL IL-8
for trauma patients (n 41). A negative correlation was
observed between reduced PaO2/FiO2 ratio and raised BAL IL-8
(r0.56, P 0.001).
In Vitro Studies 
IL-8 Secretion from Hypoxic Human Macrophages
Hypoxia was found to double IL-8 protein secretion
from macrophages by 2 hours compared to normoxic
controls (0.94	 0.28 v 0.54	 0.24 iu/ml (P 0.02).
This rapid increase was similar to that induced with
IL-1 (0.89	 0.21) and TNF- (1.1	 0.3) but signi-
ﬁcantly less than that with LPS (3.8	 0.35) (Fig. 3).
In order to determine if these ﬁndings were, in part,
due to release of intracellular stores we measured 
IL-8 in cell lysates. IL-8 levels in both hypoxic and
normoxic cells were below the level of detectability 
(4 iu/ml) at both time-points demonstrating the ab-
sence of stored IL-8 in these cells. We addressed the
possibility that the increase in IL-8 release by 2 hours
was secondary to increased TNF- or IL-1 synthesis.
Supernatant and cell-lysate levels for both cytokines
were found to be below the level of detectability
(15.6 pg/ml) and3.9 pg/ml respectively) by
ELISA.
17 patients who progressed to ARDS, BAL endotoxin
levels were at the lower limit of detection (2.5
pg/ml). Plasma endotoxin levels in patients who did
and did not progress to ARDS were also not signiﬁ-
cantly different (8.2	 23 v 6.7	 35 pg/ml, P 0.65).
A reliable initial PaO2/FiO2 ratio was available
in n 41 patients. The median value was 315 mmHg
(range 204–460). Hence, the majority of trauma
patients had evidence of signiﬁcantly impaired gas
exchange at the time of recruitment. A correlation
was observed between degree of hypoxia as mani-
fested by reduced PaO2/FiO2 ratio and raised BAL
IL-8 levels (r0.56, P  0.001) (Fig. 2). The
inﬂuence of acute hypoxia upon IL-8 generation
from human macrophages was investigated.
Fig. 1. Bronchoalveolar lavage (BAL) levels of IL-8 in pa-
tients that did and did not progress to ARDS. BAL IL-8
levels were signiﬁcantly higher in those patients that progressed
to ARDS (n 56, P 0.0001).
Table 1. Analysis of bronchoalveolar lavage ﬂuid of multiple trauma patients (n 56) who did and did not
progress to ARDS
Patients who did Patients who
not Progress Progressed
Bal Fluid to ARDS to ARDS P Value
Total protein g/ml 190 	 98 240	 142 0.6
IL-8 pg/ml 206	 288 1425	 1841 0.0001
Endotoxin pg/ml 4.5	 3.6 5.5 	 3.8 0.8
Neutrophils (%) 5 (0.5–10)* 4.5 (1–8)* 0.8
*Results expressed as mean	s.d. except [median (range)].
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Hypoxia Increases IL-8 mRNA in Human Monocyte-derived
Macrophages and Rabbit Alveolar Macrophages
The increase in IL-8 protein secretion at 2 hours
prompted us to investigate the inﬂuence of short
periods of hypoxia upon IL-8 mRNA levels. We
found that in human macrophages hypoxia in-
creased steady-state IL-8 mRNA levels at 30 mins,
1 hour, 2 hours (by 90	 50%, 104	 38% and
157 	 41% respectively, expressed as a percentage
increase over normoxic controls) (Fig. 4). Using
semi-quantitative RT-PCR, acute hypoxia was found
to increase steady-state IL-8 mRNA expression in
rabbit alveolar macrophages (Fig. 5).
Transcription Factor Activation in Hypoxic Macrophages
The increase in steady-state IL-8 mRNA might have
occurred as a consequence of increased mRNA
transcription, stability or both. Our ﬁnding that in
human macrophages hypoxia increases mRNA lev-
els as rapidly as 30 mins post-exposure suggested
that an increase in transcription at least played a part
in increasing IL-8 mRNA levels. We therefore stud-
ied the effect of hypoxia on transcription factors
known to be implicated in the regulation of IL-8
synthesis in human cells.
Since hypoxia induced a rapid upregulation of 
IL-8 mRNA levels, we ﬁrst measured by EMSA the
nuclear levels of NF-B, AP-1 and C/EBP. These
transcription factors are known to be important in
the regulation of IL-8. We compared the pattern of
expression observed with that induced by LPS, a
known potent activator of macrophages and stimu-
lus for IL-8 release.
Hypoxia increased nuclear AP-1 levels by 67	
11% and 130 	 34% at 15 and 30 mins respectively
as measured by densitometry (P 0.02, n  4). (Fig.
6A and 6B). By contrast LPS (1 g/ml) did not
signiﬁcantly activate AP-1 by 30 mins of exposure.
Fig. 3. Hypoxia stimulates IL-8 protein secretion. Human
macrophages cultured for 2 hours secreted signiﬁcantly greater
IL-8 than normoxic controls (n 9, P  0.02). The increase 
was similar to that seen with 2 hours incubation with IL-1
(10 ng/ml) and TNF- (10 ng/ml), but signiﬁcantly less than
that induced by LPS (1 g/ml) (n 4, P  0.01).
Fig. 4. Hypoxia increases IL-8 mRNA expression in hu-
man monocyte-derived macrophages. Human macrophages
were exposed to normoxia (N) or hypoxia (H). IL-8 mRNA
expression was determined by northern blot analysis. Hypoxia
signiﬁcantly increased IL-8 mRNA as measured by densitome-
try, expressed as a percentage increase over normoxic controls
(A). (P  0.01 for all time points, minimum of n  3). Repre-
sentative blots are shown (B) and comparable loading is
demonstrated with an 18s housekeeping probe.
Fig. 5. Hypoxia increases IL-8 mRNA expression in rabbit
alveolar macrophages. Rabbit alveolar macrophages were
exposed to normoxia (N), hypoxia (H) or LPS. Hypoxia
signiﬁcantly increased steady-state IL-8 mRNA expression
compared to normoxic controls by 1 and 2 hours (A).
A representative RT-PCR gel is shown (B).
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Fig. 6. Hypoxia activates AP-1. Macrophages were incubated under normoxic (N) or hypoxic (H) conditions for up to 30 min. 
and nuclear levels of AP-1 determined by electromobility gel-shift assay (EMSA). Compared to normoxic controls, (6A) hypoxia
signiﬁcantly increased AP-1 activity at 15 and 30 min. respectively as measured by densitometry (A) (n 4, P  0.02). LPS (1 g/ml)
for 30 min. does not induce AP-1 activation. PMA (100 nM), a known potent upregulator of AP-1 is used as a positive control. A rep-
resentative EMSA is shown (6B). The speciﬁcity and nature of the observed AP-1 band is addressed by super-shift assay (6C). Lane 1
contains 4 g of nuclear protein from hypoxic macrophages incubated with end-labelled AP-1 oligonucleotide probe only. Subse-
quent lanes are as Lane 1 with the addition of 100 excess cold AP-1 competitor (Lane 2), 100 excess cold non-competitor (Lane 3),
2 l rabbit serum (Lane 4 with non-speciﬁc band), c-fos antibody (Lane 5) or c-jun antibody (Lane 6 with super-shifted band).
compared to normoxic controls) but no signiﬁcant
effect with hypoxia (Fig. 9)
Role of HIF-1 in Hypoxia-induced IL-8 Generation
Whilst AP-1, C/EBP and NF-B have all previously
been implicated in IL-8 gene transcription, the
role of HIF-1 is not known. The regulation of HIF-
1 is predominantly governed by oxygen tension
(18). However cobaltous ions and iron chelators
mimic hypoxia in both induction of HIF-1 protein
and activation of HIF-1-mediated target genes
(19–22).
Macrophages exposed to normoxia, hypoxia,
CoCl (100 M), desferrioxamine (DFO) (1 mM) or
LPS (1 g/ml) for 2 hours. Immunoblotting for HIF-
1 revealed expression in hypoxic cells and those
treated with CoCl and DFO, with no expression in
normoxic cells or those treated with LPS (Fig. 10A).
However neither CoCl nor DFO increased IL-8
mRNA expression at this time point (Fig. 10B),
suggesting HIF-1 is unlikely to be implicated in
the hypoxic induction of IL-8.
Hypoxia Speciﬁcally Upregulates IL-8 mRNA
Our clinical data had speciﬁcally associated with
ARDS progression with raised IL-8 levels rather than
a range of other chemokines. We studied the effect of
2 hours hypoxia on steady state mRNA levels of a
range of chemokines using a multiprobe RNase pro-
tection assay (see methods). In contrast to the increase
in IL-8 mRNA observed (130	 18%, expressed as a
Phorbol myristate acetate (PMA) (100 nM), a known
stimulus for AP-1, was used as a positive control in
these experiments. We conﬁrmed the speciﬁcity of
the AP-1 band by competition assay and demon-
strated that the DNA-protein complex induced by
hypoxia contained the c-jun member of the AP-1
family but not c-fos. (Fig. 6C)
Hypoxia also increased nuclear C/EBP levels by
79	 9% and 82	 18% at 15 and 30 mins respec-
tively as measured by densitometry (Fig. 7A and 7B).
By comparison, LPS induced a 160	 26% increase
in levels compared to normoxic controls (P 0.02, 
n 4). The speciﬁcity of the band-shift observed was
conﬁrmed by competition assay. (Fig. 7C).
We found that hypoxia for up to 30 mins did not
increase nuclear NF-B above normoxic levels,
demonstrating that hypoxia does not lead to a gen-
eral increase in transcription factor activation. LPS
by contrast increased NF-B levels by 322	 34% by
30 mins (Fig. 8A). We conﬁrmed the speciﬁcity of
this band with a competition study, and supershift
assay with LPS-treated macrophages revealed two
supershifted bands with a p50 antibody and one
with a p65 antibody, suggesting the activated NF-B
complex contained both subunits. (Fig. 8B).
To further explore a potential activation of NF-
B by hypoxia we repeated this experiment using a
consensus oligonucleotide probe (Promega—see
methods), designed to bind to a broader spectrum of
NF-B subunits. This again revealed increased
nuclear NF-B levels with LPS (430	 54% increase
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percent increase over normoxia. P  0.01) the other
chemokines assayed were all signiﬁcantly downreg-
ulated by 2 hours hypoxia: RANTES (62	 12%), IP-
10 (100%), MIP-1 (76 	 9%), MIP-1 (52	 10%)
and MCP-1 (100%), expressed as percentage inhibi-
tion of normoxic controls (all P 0.02). LPS was
able to rapidly upregulate RANTES (590	 94%),
1P-10 (60	 38%), MIP-1 (480	 48%), MIP-1
(396	 47%) and IL-8 (410	 60%) (all P 0.02)
(Fig. 11). Hypoxia also had a small but signiﬁcant in-
hibitory effect on TNF- mRNA expression (38	
8%) whilst LPS signiﬁcantly increased expression
(610	 98%) (P  0.05 and P 0.02 respectively).
(Fig. 12)
Discussion
In this study we conﬁrmed that in multiple trauma
patients at risk of ARDS, raised initial BAL levels
of IL-8 were signiﬁcantly associated with subse-
quent progression to ARDS. We hypothesised that
physiological events in the ﬁrst few hours fol-
lowing major trauma generated intrapulmonary
IL-8 production. We found a signiﬁcant correlation
Fig. 7. Hypoxia activates C/EBP. Macrophages were incubated under normoxic (N) or hypoxic (H) conditions for up to 30 min. and
nuclear levels of C/EBP determined by EMSA (7A). Hypoxia signiﬁcantly increased C/EBP activity at 15 and 30 min. respectively as
measured by densitometry. LPS (1 g/ml for 30 min.) induces a 160	 26% increase compared to normoxic controls (P 0.02, n  4).
A representative EMSA is shown (7B). (7C) The speciﬁcity of the observed C/EBP band is addressed by competition assay. Lane 1
contains 4 g of protein from hypoxic macrophages incubated with end-labelled C/EBP oligonucleotide probe only. Lane 2 as Lane 1
with the addition of 100 excess cold non-competitor. Lanes 3, 100 excess cold C/EBP competitor. Lane 4, 1000 excess cold C/EBP
competitor.
Fig. 8. Hypoxia does not activate NF-B.
Macrophages were incubated under normoxic
(N) or hypoxic (H) conditions for up to
30 min. and nuclear levels of NF-B deter-
mined by EMSA (8A). Hypoxia does not
activate NF-B activity above basal normoxic
levels. LPS (1 g/ml for 30 min.) strongly
induces NF-B activation (n 4, P  0.01). A
representative EMSA is shown including a
competition assay (8B). Lane 3 contains 4 g
of protein from LPS-stimulated macrophages.
Lane 2 as 3 with the addition of 100 excess
cold non-competitor. Lane 1, 100 excess
cold NF-B competitor. A supershift assay
further deﬁnes this LPS-induced band (8C).
Lane 4, nuclear extracts from LPS-stimulated
macrophages (as Lane 1). Subsequent lanes
with addition of 2 l control rabbit serum
(Lane 5), p50 antibody (Lane 6) revealing two
distinct supershifted bands) or p65 antibody
(Lane 7 revealing one supershifted band).
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One strategy for investigating the pathogenesis of
ARDS is to focus on patients at-risk of developing
ARDS, in particular delineating those key early
inﬂammatory events which may be associated with
subsequent disease progression. Our initial report,
based on patients (n 29) with a variety of risk-
factors for ARDS, revealed an association between
raised bronchoalveolar lavage (BAL) levels of IL-8
and progression to ARDS (6). In this extended study
we have focused on a larger, well-deﬁned at-risk pop-
ulation of trauma victims. Our original observation
that raised initial alveolar IL-8 levels are associated
with ARDS progression was conﬁrmed. Investigating
potential mechanisms by which intrapulmonary IL-8
is rapidly generated may therefore be key to our un-
derstanding of the pathogenesis of lung injury.
Several studies have identiﬁed raised IL-8 levels
in the BAL ﬂuid of patients with established severe
lung injury and ARDS (24–26). We are conﬁdent that
the raised intrapulmonary IL-8 levels detected in our
patients was present before the onset of signiﬁcant
lung injury based upon the following observations:
1) we were able to target patients very soon after the
trauma event (median 95 min), with no patient re-
cruited after 4 hours. At this time no patient studied
had characteristic chest radiographic appearances of
ARDS; 2) lung leak, as assessed by total protein con-
centrations in BAL ﬂuid, was low (240	 142 g/ml
in the patients who progressed to ARDS). Previous
studies have shown that BAL levels of total protein
in established ARDS are 5–10 fold higher than that
found in our at-risk population. (27–29); 3) the 
median BAL neutrophil count was 5% for our at-risk
population. Again, this is strikingly lower than
would be found in established disease, in which
neutrophils typically represent over 50% of the BAL
cell population (27,28,30).
Our clinical studies demonstrate a temporal asso-
ciation between IL-8 generation and development of
lung injury, though not necessarily causation. How-
ever interleukin-8 is regarded as the most potent
neutrophil chemokine in the lung (31). In patients
with established ARDS, IL-8 has been shown to 
between patient hypoxia, as indicated by a reduced
PaO2/FiO2 ratio on admission, and raised intrapul-
monary IL-8 levels (r  0.56, P  0.02). In subse-
quent in vitro studies we demonstrated for the ﬁrst
time that clinically relevant short periods of hy-
poxia upregulated synthesis of IL-8. Hypoxia was
shown to increase DNA binding activity of the
transcription factors AP-1 and C/EBP, but not NF-
B, within 15 mins of hypoxic exposure, a pattern
of activation which differs from that observed with
LPS. Hypoxic macrophages expressed HIF-1, but
our studies with cobaltous ions and DFO suggest
that HIF-1 may not be implicated in IL-8 regulation.
Both the pattern of transcription factor activition
and chemokine expression were different to that ob-
served with the classical proinﬂammatory mediator,
endotoxin.
It is acknowledged that ARDS represents the
severe end of a spectrum of acute lung injury (23).
Fig. 9. Hypoxia does not activate NF-B—using a consensus
oligonucleotide probe. Macrophages incubated as previously for
30 min. and nuclear levels of NF-B determined by EMSA using
a consensus oligonucleotide probe (see methods) (9A). Hypoxia
does not activate NF-B activity above basal normoxic levels. LPS
(1 g/ml for 30 mins) strongly induces NF-B activation. (n 4,
P 0.01). A representative EMSA is shown, demonstrating that
the concensus probe reveals two distinct NF-B bands, of which
the upper (arrowed) is inducible by LPS (9B).
Fig. 10. HIF-1 expression in human
macrophages. Macrophages were incubated un-
der normoxic (N) or hypoxic (H) conditions, or
treated with LPS, 100 M CoCl or 1 mM desfer-
rioxamine (DFO), for 2 hours. HIF-1 protein ex-
pression was determined by immunoblotting total
nuclear extract. Hypoxia, CoCl and DFO all induce
HIF-1, with no expression under normoxic con-
ditions or following LPS treatment (10A). IL-8
mRNA expression was determined by northern
blotting (10B). An 18s housekeeping probe was
used to verify equal RNA loading (10C). Relative
densitometry, corrected for RNA loading, from 
n 3 experiments is shown in panel (10D).
Neither CoCl nor DFO mimicked the hypoxia-
induced increased in IL-8 mRNA expression.
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be responsible for over 50% of the neutrophil
chemotactic activity of BAL ﬂuid (32). In animal
models, acute lung injury secondary to ischaemia/
reperfusion (33), alveolar collapse/re-expansion (34)
and acid instillation (35) is signiﬁcantly attenuated
by administration of anti-IL-8 antibody. These studies
suggest that raised IL-8 levels may therefore play a
central role in driving the pulmonary inﬂammatory
response in acute lung injury.
In our in vitro studies, monocyte-derived macro-
phages were exposed to a PO2 of 26 mmHg. The pre-
cursor of the alveolar macrophages is the peripheral
circulating monocyte (36–38), hence macrophages
matured from monocytes provide a reasonable model
for in vitro studies. We showed that our principle ﬁnd-
ing of hypoxic upregulation of IL-8 mRNA was also
seen in rabbit alveolar macrophages. We believe that the
degree of hypoxia employed may be physiologically
relevant in the alveolar air-spaces of patients with
multiple trauma. In the immediate aftermath of major
trauma, impaired consciousness, lung atelectasis, pul-
monary contusion and intrapulmonary shunting are
all likely to contribute to signiﬁcant alveolar hypoxia
and impaired gas exchange (39–42). These factors
would account for the reduced PaO2/FiO2 observed
in our trauma patients in the absence of severe lung
injury. Direct measurement of tissue oxygenation 
in vivo was however not feasible in our studies.
We demonstrated that in human macrophages
IL-8 protein secretion was increased within 2 hours,
and mRNA expression within 30 minutes of hypoxic
exposure; a time-frame relevant to our clinical ﬁnd-
ings. Importantly the degree of stimulation at this time
point was similar to that seen with the archetypal early
pro-inﬂammatory mediators TNF- and IL-1. The up-
regulation of IL-8 mRNA in macrophages by hypoxia
Fig. 11. and Fig. 12. Hypoxia selectively upregulates IL-8
mRNA expression. Macrophages were exposed to normoxia
(N), hypoxia (H) or LPS (1 g/ml) for 2 hours and RNase
protection assay performed with multiple RNA riboprobes
(see methods). IL-8 is the only mRNA species to be upregu-
lated by hypoxia. RANTES*, IP-10*, MIP-1, MIP-1 and
MCP-1 were all downregulated by hypoxia (P 0.02) (11A).
In contrast, LPS signiﬁcantly upregulated the majority of
chemokines (P 0.02) (11B). A representative gel is shown
(11C). For clarity the probe template is not shown.
(*Expression of RANTES and IP-10 was comparatively low.
Prolonged radiographic exposure for 3 days however revealed
a clear normoxic RANTES and IP-10 bands and reduced
expression under hypoxic conditions.) Hypoxia inhibited
TNF- expression (P 0.05) and LPS signiﬁcantly increased
expression (P 0.02) (12A). A representative gel is shown
(12B).
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initiation site. The regulation of HIF-1 is predomi-
nantly governed by oxygen tension (18). However
cobaltous ions and iron chelators mimic hypoxia in
both induction of HIF-1 protein and activation of
a number of HIF-1-mediated target genes (19–22).
Our observation that HIF-1 expression was induced
by hypoxia, cobaltous ions and DFO, but that these
pharmacological mimics of hypoxia did not increase
IL-8 mRNA expression suggests that HIF-1 may not
be involved in IL-8 regulation.
Finally, we considered the potential selectivity of
the IL-8 response and the effect of brief hypoxia on
other macrophage-derived chemokines and cyto-
kines. We found that mRNA expression of several
chemokines, in contrast to IL-8, were clearly down-
regulated by hypoxia. For example MIP-1, a CC
chemokine with monocyte and neutrophil chemoat-
tractant properties was inhibited by 2 hours hypoxia
exposure. Similarly, mRNA expression of the arche-
typal early proinﬂammatory cytokine TNF- was
reduced under hypoxic conditions. These ﬁndings
provide further evidence that hypoxia-induced
transcription of these chemokines in macrophages is
independent of NF-B. As with IL-8, the promoter
regions of MCP-1, MIP-, and TNF, all harbour func-
tionally important NF-B binding sites. Hypoxia
downregulates steady-state mRNA expression of
these mediators without reducing NF-B DNA bind-
ing activity to a concensus probe. In contrast LPS
has the capacity to upregulate a broad spectrum of
inﬂammatory mediators, in association with in-
creased NF-B activation.
These studies were prompted by our observation
that raised intrapulmonary IL-8 levels were associated
with ARDS progression in at-risk patients. In human
macrophages acute hypoxia selectively upregulated
IL-8 expression, in association with a novel pattern of
transcription factor activation. However, the in vitro ef-
fects of hypoxia alone do not appear to be of sufﬁcient
magnitude to account for the differences in IL-8 ob-
served in the clinical studies. Hypoxia is unlikely to
represent the only relevant stimulus for IL-8 genera-
tion in the clinical setting. Rather several potentially
proinﬂammatory stimuli including initial hypoxia,
followed by reoxygenation/hyperoxia and pulmonary
barotrauma during resuscitation and ventilation may
create ‘multiple-hits’ to induce signiﬁcant IL-8 gener-
ation and progression to ARDS. We are currently ex-
ploring this hypothesis in on-going studies.
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